NASDAQ:HCP - HashiCorp Inc - Class A Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $67.17
  • Forecasted Upside: 124.11 %
  • Number of Analysts: 14
  • Breakdown:
  • 0 Sell Ratings
  • 6 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$29.97
▲ +0.53 (1.80%)
Get New HashiCorp Inc - Class A Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HCP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HCP

Analyst Price Target is $67.17
▲ +124.11% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for HashiCorp Inc - Class A in the last 3 months. The average price target is $67.17, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 124.11% upside from the last price of $29.97.

This chart shows the closing price for HCP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 14 contributing investment analysts is to buy stock in HashiCorp Inc - Class A. This rating has held steady since September 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/9/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/7/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 0 sell ratings
1/5/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/5/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 6 hold ratings
  • 0 sell ratings
6/4/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 6 hold ratings
  • 0 sell ratings
7/4/2022

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 6 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/6/2022The Goldman Sachs GroupLower Price TargetNeutral$59.00 ➝ $53.00N/A
6/3/2022OppenheimerLower Price Target$70.00N/A
6/3/2022JMP SecuritiesLower Price TargetMarket Outperform$68.00 ➝ $54.00N/A
6/3/2022Stifel NicolausLower Price Target$60.00 ➝ $51.00N/A
6/3/2022Piper SandlerLower Price TargetNeutral$59.00 ➝ $46.00N/A
5/27/2022CowenLower Price Target$48.00N/A
5/19/2022Morgan StanleyLower Price TargetEqual Weight$50.00 ➝ $47.00N/A
4/14/2022The Goldman Sachs GroupLower Price TargetNeutral$77.00 ➝ $59.00N/A
4/12/2022Piper SandlerInitiated CoverageNeutral$59.00N/A
3/31/2022Bank of AmericaBoost Price TargetBuy$55.00 ➝ $65.00N/A
3/14/2022Morgan StanleyLower Price TargetEqual Weight$90.00 ➝ $50.00N/A
3/11/2022JMP SecuritiesLower Price TargetMarket Outperform$110.00 ➝ $68.00N/A
3/1/2022CitigroupLower Price Target$100.00 ➝ $62.00N/A
1/4/2022Stifel EuropeInitiated CoverageBuyN/A
1/4/2022CitigroupInitiated CoverageNeutral$100.00N/A
1/3/2022OppenheimerInitiated CoverageOutperform$110.00N/A
1/3/2022Stifel NicolausInitiated CoverageBuy$100.00N/A
1/3/2022Wolfe ResearchInitiated CoverageOutperform$105.00N/A
1/3/2022Bank of AmericaInitiated CoverageBuy$102.00N/A
1/3/2022Morgan StanleyInitiated CoverageEqual Weight$90.00N/A
1/3/2022JMP SecuritiesInitiated CoverageOutperform$110.00N/A
1/3/2022JPMorgan Chase & Co.Initiated CoverageNeutral$100.00N/A
1/3/2022CowenInitiated CoverageOutperform$105.00N/A
1/3/2022William BlairInitiated CoverageOutperformN/A
1/3/2022The Goldman Sachs GroupInitiated CoverageNeutral$90.00N/A
1/3/2022KeyCorpInitiated CoverageSector Weight ➝ Sector WeightN/A
10/8/2019JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$35.00 ➝ $38.00Low
10/2/2019BarclaysBoost Price TargetOverweight$37.00 ➝ $39.00Low
10/2/2019KeyCorpBoost Price TargetOverweight$34.00 ➝ $37.00Low
9/30/2019ScotiabankSet Price TargetBuy$38.00Medium
9/17/2019Morgan StanleyBoost Price TargetEqual Weight$32.00 ➝ $35.00High
9/10/2019JPMorgan Chase & Co.Boost Price TargetNeutral$32.00 ➝ $35.00High
9/10/2019ArgusUpgradeHold ➝ BuyHigh
9/3/2019BarclaysInitiated CoverageOverweight$37.00High
9/3/2019Stifel NicolausBoost Price TargetBuy$34.00 ➝ $37.00High
8/1/2019Stifel NicolausBoost Price TargetBuy$32.00 ➝ $34.00Medium
7/1/2019KeyCorpBoost Price TargetOverweight$32.00 ➝ $34.00Medium
6/13/2019Raymond JamesUpgradeMarket Perform ➝ Outperform$35.00Medium
3/28/2019Morgan StanleySet Price TargetHold$32.00Medium
2/13/2019BMO Capital MarketsReiterated RatingBuy$33.00Low
1/9/2019BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$30.00 ➝ $33.00Low
1/7/2019Robert W. BairdUpgradeNeutral ➝ OutperformMedium
12/10/2018ScotiabankInitiated CoverageOutperform$32.00Medium
11/2/2018Royal Bank of CanadaUpgradeSector Perform ➝ OutperformMedium
11/1/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $30.00Medium
10/31/2018BMO Capital MarketsReiterated RatingHold$27.00High
10/5/2018JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralLow
9/27/2018Cantor FitzgeraldUpgradeNeutral ➝ Overweight$28.00 ➝ $29.00High
9/17/2018Bank of AmericaBoost Price TargetBuy$27.50 ➝ $28.00Medium
8/16/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$23.50 ➝ $25.00Low
8/13/2018MizuhoReiterated RatingBuy$29.00Low
8/9/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$24.00 ➝ $26.00Low
8/7/2018Cantor FitzgeraldInitiated CoverageNeutral$28.00Low
8/3/2018Stifel NicolausSet Price TargetBuy ➝ Buy$27.00 ➝ $28.00Low
7/24/2018Capital One FinancialInitiated CoverageEqual Weight$27.50Low
7/23/2018Capital One FinancialReiterated RatingEqual WeightLow
6/14/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$28.00 ➝ $23.50Low
6/1/2018Raymond JamesReiterated RatingMarket PerformLow
6/1/2018Evercore ISIDowngradeIn-Line ➝ UnderperformLow
5/21/2018Evercore ISIDowngradeIn-Line ➝ Underperform$23.02 ➝ $24.00Low
5/21/2018Raymond JamesDowngradeOutperform ➝ Market PerformLow
5/3/2018BMO Capital MarketsReiterated RatingHold$25.00Low
3/20/2018Wells Fargo & CompanyLower Price TargetMarket Perform ➝ Market Perform$31.00 ➝ $27.00Low
3/8/2018Bank of AmericaUpgradeNeutral ➝ Buy$22.63 ➝ $25.00Low
2/23/2018Royal Bank of CanadaReiterated RatingHold$27.00Low
2/21/2018UBS GroupReiterated RatingSell ➝ Sell$25.00 ➝ $21.00Medium
2/15/2018Robert W. BairdSet Price TargetHold$24.00Low
2/15/2018MizuhoSet Price TargetBuy$26.00Low
2/14/2018Stifel NicolausReiterated RatingBuy ➝ Buy$29.00 ➝ $27.00High
2/13/2018Jefferies Financial GroupReiterated RatingHold$26.00Medium
2/13/2018BMO Capital MarketsSet Price TargetHold$25.00Medium
1/15/2018BMO Capital MarketsSet Price TargetHold$25.00Low
1/5/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$29.00 ➝ $26.00Medium
12/15/2017JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$29.00Medium
12/14/2017Morgan StanleyReiterated RatingEqual Weight$29.00Low
12/5/2017Stifel NicolausUpgradeHold ➝ Buy$29.00Low
11/7/2017Stifel NicolausLower Price TargetHold ➝ Hold$30.00 ➝ $29.00N/A
11/2/2017MizuhoUpgradeNeutral ➝ Buy$32.00N/A
10/18/2017BMO Capital MarketsReiterated RatingHold$28.00N/A
10/17/2017KeyCorpReiterated RatingHoldN/A
10/4/2017Stifel NicolausReiterated RatingHold$30.00Low
10/2/2017UBS GroupDowngradeNeutral ➝ Sell$30.00 ➝ $25.00High
9/25/2017Morgan StanleyLower Price TargetEqual Weight$31.00 ➝ $29.00Low
9/22/2017Bank of AmericaDowngradeBuy ➝ Neutral$33.00 ➝ $31.00High
9/17/2017KeyCorpReiterated RatingHoldLow
9/6/2017BMO Capital MarketsReiterated RatingHold$32.00Low
8/22/2017Stifel NicolausReiterated RatingHold$30.00Medium
7/25/2017Jefferies Financial GroupReiterated RatingHold$33.00Low
7/24/2017The Goldman Sachs GroupDowngradeBuy ➝ Neutral$35.00 ➝ $32.00Medium
7/14/2017Stifel NicolausReiterated RatingHold$31.00Medium
7/5/2017Royal Bank of CanadaReiterated RatingHold$31.00High
(Data available from 7/5/2017 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/6/2021
  • 2 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/5/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/4/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/6/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/5/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
5/5/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/4/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/4/2022

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
HashiCorp Inc - Class A logo
HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Read More

Today's Range

Now: $29.97
Low: $28.29
High: $30.65

50 Day Range

MA: $30.54
Low: $28.42
High: $35.78

52 Week Range

Now: $29.97
Low: $26.58
High: $37.93

Volume

816,735 shs

Average Volume

2,123,049 shs

Market Capitalization

$5.53 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of HashiCorp Inc - Class A?

The following sell-side analysts have issued stock ratings on HashiCorp Inc - Class A in the last year: Bank of America Co., Citigroup Inc., Cowen Inc, Cowen Inc., JMP Securities, JPMorgan Chase & Co., KeyCorp, Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Stifel Europe, Stifel Nicolaus, The Goldman Sachs Group, Inc., William Blair, and Wolfe Research.
View the latest analyst ratings for HCP.

What is the current price target for HashiCorp Inc - Class A?

0 Wall Street analysts have set twelve-month price targets for HashiCorp Inc - Class A in the last year. Their average twelve-month price target is $67.17, suggesting a possible upside of 124.1%.
View the latest price targets for HCP.

What is the current consensus analyst rating for HashiCorp Inc - Class A?

HashiCorp Inc - Class A currently has 6 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HCP will outperform the market and that investors should add to their positions of HashiCorp Inc - Class A.
View the latest ratings for HCP.

How do I contact HashiCorp Inc - Class A's investor relations team?

HashiCorp Inc - Class A's physical mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The real estate investment trust's listed phone number is 415-301-3227 and its investor relations email address is [email protected] The official website for HashiCorp Inc - Class A is www.hcpi.com. Learn More about contacing HashiCorp Inc - Class A investor relations.